相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synthesis of a Sugar-Based Thiosemicarbazone Series and Structure-Activity Relationship versus the Parasite Cysteine Proteases Rhodesain, Cruzain, and Schistosoma mansoni Cathepsin B1
Nayara Cristina Fonseca et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Polo-Like Kinase 1 as a Potential Therapeutic Target for Osteosarcoma
Li Cheng et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Schistosomiasis and its treatment
Conor R. Caffrey
FUTURE MEDICINAL CHEMISTRY (2015)
ANTHELMINTIC DRUG DISCOVERY: INTO THE FUTURE
Timothy G. Geary et al.
JOURNAL OF PARASITOLOGY (2015)
Natural Products as Leads in Schistosome Drug Discovery
Bruno J. Neves et al.
MOLECULES (2015)
Anti-Schistosomal Activity of Cinnamic Acid Esters: Eugenyl and Thymyl Cinnamate Induce Cytoplasmic Vacuoles and Death in Schistosomula of Schistosoma mansoni
Jan Glaser et al.
MOLECULES (2015)
Application of RNAi to Genomic Drug Target Validation in Schistosomes
Alessandra Guidi et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
The QDREC web server: determining dose-response characteristics of complex macroparasites in phenotypic drug screens
Daniel Asarnow et al.
BIOINFORMATICS (2015)
Thoughts on the current assessment of Polo-like kinase inhibitor drug discovery
Klaus Strebhardt et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy
B. T. Gjertsen et al.
LEUKEMIA (2015)
Repurposing of the Open Access Malaria Box for Kinetoplastid Diseases Identifies Novel Active Scaffolds against Trypanosomatids
Marcel Kaiser et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Efficacy and Mechanism of Action of Volasertib, a Potent and Selective Inhibitor of Polo-Like Kinases, in Preclinical Models of Acute Myeloid Leukemia
Dorothea Rudolph et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Current assessment of polo-like kinases as anti-tumor drug targets
Sandra N. Craig et al.
EXPERT OPINION ON DRUG DISCOVERY (2014)
Volasertib for the treatment of acute myeloid leukemia: a review of preclinical and clinical development
Melanie Janning et al.
FUTURE ONCOLOGY (2014)
The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer)
Piero Olliaro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Schistosomiasis control: praziquantel forever?
Donato Cioli et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2014)
The discovery of first-in-class drugs: origins and evolution
Joerg Eder et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Polo-like kinases: structural variations lead to multiple functions
Sihem Zitouni et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Chemical and Genetic Validation of the Statin Drug Target to Treat the Helminth Disease, Schistosomiasis
Liliana Rojo-Arreola et al.
PLOS ONE (2014)
Repurposing human Aurora kinase inhibitors as leads for anti-protozoan drug discovery
Gautam Patel et al.
MEDCHEMCOMM (2014)
Orally Active Antischistosomal Early Leads Identified from the Open Access Malaria Box
Katrin Ingram-Sieber et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Serum albumin and α-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor Imatinib
Svenja Beckmann et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2014)
Compound library screening identified Akt/PKB kinase pathway inhibitors as potential key molecules for the development of new chemotherapeutics against schistosomiasis
Marion Morel et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2014)
Schistosomiasis Chemotherapy
Sophie A. -L. Thetiot-Laurent et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Segmenting the Etiological Agent of Schistosomiasis for High-Content Screening
Daniel E. Asarnow et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2013)
Genetic and Molecular Basis of Drug Resistance and Species-Specific Drug Action in Schistosome Parasites
Claudia L. L. Valentim et al.
SCIENCE (2013)
Polo-Like Kinases Inhibitors
L. Garuti et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy
Jonathan A. Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Susceptibility or resistance of praziquantel in human schistosomiasis: a review
Wei Wang et al.
PARASITOLOGY RESEARCH (2012)
SmSak, the Second Polo-Like Kinase of the Helminth Parasite Schistosoma mansoni: Conserved and Unexpected Roles in Meiosis
Thavy Long et al.
PLOS ONE (2012)
Whole Organism High-Content Screening by Label-Free, Image-Based Bayesian Classification for Parasitic Diseases
Ross A. Paveley et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Polo-Box Domain Inhibitor Poloxin Activates the Spindle Assembly Checkpoint and Inhibits Tumor Growth in Vivo
Juping Yuan et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Schistosoma mansoni Polo-like kinases and their function in control of mitosis and parasite reproduction
Colette Dissous et al.
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2011)
Eukaryotic Protein Kinases (ePKs) of the Helminth Parasite Schistosoma mansoni
Luiza F. Andrade et al.
BMC GENOMICS (2011)
From Plk1 to Plk5 Functional evolution of Polo-like kinases
Guillermo de Carcer et al.
CELL CYCLE (2011)
Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies
David Olmos et al.
CLINICAL CANCER RESEARCH (2011)
Schistosomiasis: from drug deployment to drug development
Conor R. Caffrey et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
How were new medicines discovered?
David C. Swinney et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: Potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties
Tara R. Rheault et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Schistosoma mansoni Polo-like kinase 1: A mitotic kinase with key functions in parasite reproduction
Thavy Long et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2010)
Sensitivity of Cancer Cells to Plk1 Inhibitor GSK461364A Is Associated with Loss of p53 Function and Chromosome Instability
Yan Degenhardt et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
Klaus Strebhardt
NATURE REVIEWS DRUG DISCOVERY (2010)
RNA Interference in Schistosoma mansoni Schistosomula: Selectivity, Sensitivity and Operation for Larger-Scale Screening
Sasa Stefanic et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Discovery of thiophene inhibitors of polo-like kinase
Kyle A. Emmitte et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding
Kyle A. Emmitte et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Distinct Concentration-Dependent Effects of the Polo-like Kinase 1-Specific Inhibitor GSK461364A, Including Differential Effect on Apoptosis
Aidan G. Gilmartin et al.
CANCER RESEARCH (2009)
A Pan-Specific Inhibitor of the Polo-Box Domains of Polo-like Kinases Arrests Cancer Cells in Mitosis
Wolfgang Reindl et al.
CHEMBIOCHEM (2009)
BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity
Dorothea Rudolph et al.
CLINICAL CANCER RESEARCH (2009)
Towards an understanding of the mechanism of action of praziquantel
Anthony D. Aragon et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2009)
Polo-like kinases: conservation and divergence in their functions and regulation
Vincent Archambault et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use
Rashad A. Abdul-Ghani et al.
PARASITOLOGY RESEARCH (2009)
A Schistosome cAMP-Dependent Protein Kinase Catalytic Subunit Is Essential for Parasite Viability
Brett E. Swierczewski et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
SmCL3, a Gastrodermal Cysteine Protease of the Human Blood Fluke Schistosoma mansoni
Jan Dvorak et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Drug Discovery for Schistosomiasis: Hit and Lead Compounds Identified in a Library of Known Drugs by Medium-Throughput Phenotypic Screening
Maha-Hamadien Abdulla et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Taste, A New Incentive to Switch to (R)-Praziquantel in Schistosomiasis Treatment
Thorsten Meyer et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Inhibition of polo-like kinase 1 by blocking Polo-box domain-dependent protein-protein interactions
Wolfgang Reindl et al.
CHEMISTRY & BIOLOGY (2008)
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis
Michael J. Doenhoff et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2008)
Yeast Polo-like kinase substrates are nailed with the right tools
Vincent Archambault et al.
GENOME BIOLOGY (2008)
Schistosomes: challenges in compound screening
Bernadette Ramirez et al.
EXPERT OPINION ON DRUG DISCOVERY (2007)
Thioredoxin glutathione reductase from schistosoma mansoni:: An essential parasite enzyme and a key drug target
Angela N. Kuntz et al.
PLOS MEDICINE (2007)
The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1
Peter Lenart et al.
CURRENT BIOLOGY (2007)
BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo
Martin Steegmaier et al.
CURRENT BIOLOGY (2007)
In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1
Timothy J. Lansing et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Schistosomiasis mansoni: Novel chemotherapy using a cysteine protease inhibitor
Maha-Hamadien Abdulla et al.
PLOS MEDICINE (2007)
A clinical drug library screen identifies astemizole as an antimalarial agent
Curtis R. Chong et al.
NATURE CHEMICAL BIOLOGY (2006)
Polo-like kinases (Plks) and cancer
N Takai et al.
ONCOGENE (2005)
Polo-like kinases and the orchestration of cell division
FA Barr et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
